Biohaven Ltd. (BHVN) has a negative trailing P/E of -1.5, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 40.9 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -67.18%, forward earnings yield 2.45%.
Criteria proven by this page:
Overall SharesGrow Score: 47/100 with 2/7 criteria passed.
| Year | P/E (TTM) | PEG Ratio | P/B Ratio | P/S Ratio | Dividend Yield |
|---|---|---|---|---|---|
| 2017 | 0.0 | 0.00 | 0.00 | 0.00 | - |
| 2018 | 0.0 | 0.00 | 0.00 | 0.00 | - |
| 2019 | -0.7 | 0.00 | -47.68 | 0.00 | - |
| 2020 | -2.2 | 0.03 | 15.58 | 0.00 | - |
| 2021 | -1.2 | -0.02 | 7.54 | 0.00 | - |
| 2022 | -1.1 | -0.01 | 1.15 | 0.00 | - |
| 2023 | -7.5 | 0.14 | 7.12 | 0.00 | - |
| 2024 | -4.0 | -0.06 | 8.05 | 0.00 | - |
| 2025 | -1.6 | 0.06 | 23.33 | 0.00 | - |
| Year | EPS (Diluted) | Revenue | Net Income | Net Margin |
|---|---|---|---|---|
| 2017 | $0.00 | $0.00 | $0.00 | - |
| 2019 | $-10.91 | $0.00 | $-528.81M | - |
| 2020 | $-3.31 | $0.00 | $-118.67M | - |
| 2021 | $-5.97 | $462.51M | $-213.8M | -46.2% |
| 2022 | $-12.75 | $0.00 | $-570.28M | - |
| 2023 | $-5.73 | $0.00 | $-408.17M | - |
| 2024 | $-9.28 | $0.00 | $-846.42M | - |
| 2025 | $-6.86 | $0.00 | $-738.82M | - |
| Year | EPS (Avg) | EPS Range | Revenue (Avg) | Revenue Range | Analysts |
|---|---|---|---|---|---|
| 2026 | $-2.98 | $-4.44 – $-2.15 | $2.45M | $1.78M – $3.3M | 11 |
| 2027 | $-2.55 | $-3.76 – $-1.62 | $19.68M | $9.7M – $32.22M | 10 |
| 2028 | $-2.25 | $-4.07 – $-0.10 | $112.45M | $112.43M – $112.48M | 11 |
| 2029 | $-1.47 | $-2.13 – $-0.94 | $325.5M | $235.95M – $438.02M | 4 |
| 2030 | $0.26 | $0.16 – $0.37 | $779.87M | $565.31M – $1.05B | 4 |
